Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
Recruiting now Phase 2 NCT07090161
Run by Vanda Pharmaceuticals · for 18 to 65 · All sexes
What this study is about
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Iloperidone for the Treatment of Participants with Uncontrolled Hypertension
Who can join (things the study team will check)
✅ You may be able to join if…
- SiSBP >/= 130 mmHg despite >8 weeks treatment w/ 1 or more antihypertensive therapies
🚫 You may not be able to join if…
- Confirmed Grade 3/severe hypertension (SiSBP >/= 180 mmHg, SiDBP >/= 120 mmHg), unstable cardiac disease, renal insufficiency
Where this trial is running
- Vanda Investigative Site, Phoenix, Arizona, United States
- Vanda Investigative Site, Tempe, Arizona, United States
- Vanda Investigative Site, Tucson, Arizona, United States
- Vanda Investigative Site, Chula Vista, California, United States
- Vanda Investigative Site, Dublin, California, United States
- Vanda Investigative Site, Valencia, California, United States
- Vanda Investigative Site, Walnut Creek, California, United States
- Vanda Investigative Site, Doral, Florida, United States
- Vanda Investigative Site, Fort Myers, Florida, United States
- Vanda Investigative Site, Columbus, Georgia, United States
- Vanda Investigative Site, Oak Brook, Illinois, United States
- Vanda Investigative Site, Tinley Park, Illinois, United States
+ 16 more sites.
Who to contact
Vanda Pharmaceuticals, Inc. · 202-734-3400 · clinicaltrials@vandapharma.com
It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT07090161.
Verify everything on the official ClinicalTrials.gov record. Page updated July 2026.
Beacon is an information tool, not medical advice. Whether a trial is right for you is a decision for you, your doctor, and the study team. Trial details come from the official registry, ClinicalTrials.gov, and may change — always confirm with the study team. Beacon collects no data about you: this page has no cookies, no accounts, and no tracking.